USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Ultrathermics Inc
Address: 7126 180th Ave Ne
Redmond, WA 98052
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $151,695.00 3
SBIR Phase II $250,000.00 1

Award List:

HYPERTHERMIA THERAPY IS BECOMING ACCEPTED AS THE FOURTH MAJOR WEAPON IN THE ARSENAL OF THE CANCER THERAPIST.

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas l. anderson , PRINCIPAL INVESTIGATOR
Award Amount: $50,000.00
Abstract:
Hyperthermia therapy is becoming accepted as the fourth major weapon in the arsenal of the cancer therapist. however, its transition into routine medical practice is being severely hindered by the lack of commercial equipment capable of selectively heating deep-seated tumors to therapeutic… More

AN ULTRASOUND-BASED PSORIASIS TREATMENT SYSTEM

Award Year / Program / Phase: 1985 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas L. Anderson , Principal Investigator
Award Amount: $51,695.00

AN ULTRASOUND-BASED PSORIASIS TREATMENT SYSTEM

Award Year / Program / Phase: 1987 / SBIR / Phase II
Agency: HHS
Principal Investigator: Thomas L. Anderson , Principal Investigator
Award Amount: $250,000.00
Abstract:
Psoriasis is a disease for which new modalities of treatment are needed, especially for chronic, plaque-type lesions with limited skin distribution. patients and physicians alike are frustrated because none of the existing therapies is completely satisfactory. preliminary clinical studies indicate… More

AN ULTRASOUND SYSTEM FOR THE TREATMENT OF WARTS

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
Viral warts are an affliction for which new modalities of treatment are needed, especially for large, flat, resistant and/or clustered lesions. patients and physicians alike arefrustrated because none of the existing therapies is completely satisfactory. preliminary clinical studies indicate that… More